Xenon Pharmaceuticals, Inc. (XENE)
34.44
-1.36
(-3.81%)
USD |
NASDAQ |
Oct 13, 16:00
34.49
+0.04
(+0.13%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash and Short Term Investments (Quarterly) : 930.69M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 930.69M |
| March 31, 2026 | 1.095B |
| December 31, 2025 | 548.89M |
| September 30, 2025 | 462.27M |
| June 30, 2025 | 487.54M |
| March 31, 2025 | 549.63M |
| December 31, 2024 | 626.90M |
| September 30, 2024 | 654.02M |
| June 30, 2024 | 721.54M |
| March 31, 2024 | 699.60M |
| December 31, 2023 | 638.08M |
| September 30, 2023 | 526.67M |
| June 30, 2023 | 539.60M |
| March 31, 2023 | 527.04M |
| December 31, 2022 | 592.09M |
| September 30, 2022 | 638.18M |
| June 30, 2022 | 788.24M |
| March 31, 2022 | 537.94M |
| December 31, 2021 | 551.77M |
| September 30, 2021 | 249.62M |
| June 30, 2021 | 260.52M |
| March 31, 2021 | 274.70M |
| December 31, 2020 | 177.00M |
| September 30, 2020 | 190.93M |
| June 30, 2020 | 202.75M |
| Date | Value |
|---|---|
| March 31, 2020 | 229.67M |
| December 31, 2019 | 141.36M |
| September 30, 2019 | 94.60M |
| June 30, 2019 | 101.80M |
| March 31, 2019 | 110.43M |
| December 31, 2018 | 119.31M |
| September 30, 2018 | 127.13M |
| June 30, 2018 | 63.27M |
| March 31, 2018 | 35.08M |
| December 31, 2017 | 43.67M |
| September 30, 2017 | 43.77M |
| June 30, 2017 | 51.70M |
| March 31, 2017 | 58.03M |
| December 31, 2016 | 64.15M |
| September 30, 2016 | 69.49M |
| June 30, 2016 | 50.74M |
| March 31, 2016 | 56.06M |
| December 31, 2015 | 58.65M |
| September 30, 2015 | 65.47M |
| June 30, 2015 | 73.70M |
| March 31, 2015 | 75.38M |
| December 31, 2014 | 84.04M |
| September 30, 2014 | 47.94M |
| June 30, 2014 | 44.71M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Psyence Biomedical Ltd. | 7.197M |
| Aurinia Pharmaceuticals, Inc. | 443.12M |
| enGene Therapeutics, Inc. | 266.40M |
| Medicus Pharma Ltd. | 10.70M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |